Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
104.06-1.76 (-1.66%)
At close: 03:59PM EDT
104.77 +0.71 (+0.68%)
After hours: 04:06PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Up

Gap Up

Previous Close105.82
Open105.06
Bid103.74 x 800
Ask103.83 x 800
Day's Range103.33 - 105.32
52 Week Range91.51 - 122.16
Volume991,461
Avg. Volume1,641,015
Market Cap230.263B
Beta (5Y Monthly)0.31
PE Ratio (TTM)35.64
EPS (TTM)2.92
Earnings DateN/A
Forward Dividend & Yield1.60 (1.51%)
Ex-Dividend DateAug 12, 2022
1y Target Est129.48
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
2% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NVO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novo Nordisk A/S
    Analyst Report: Novo Nordisk A/SWith almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
    Rating
    Fair Value
    Economic Moat
    18 days agoMorningstar
View more
Advertisement
Advertisement